STEPHANIE BURNS, PH.D.

Corporate Board Profile

Tech Score: 0/100

KELLANOVA

Filing Date	Source Excerpt
2020-03-10	Stephanie A. Burns, Ph.D. Dr. Burns, age 65, has served as a Kellogg Director since February 2014. Dr. Burns served as Chief Executive Officer of Dow Corning Corporation from 2004 to 2011 and its Chairman from 2006 through 2011. She began her career with Dow Corning in 1983 and later became Dow Corning’s first director of women’s health. Dr. Burns was elected to the Dow Corning Board of Directors in 2001 and elected as President in 2003. Dr. Burns is a director of Corning Incorporated and HP Inc., and within the past five years, Dr. Burns has also served as a director of GlaxoSmithKline plc. As a result of these professional and other experiences, Dr. Burns has been determined to be an “Audit Committee Financial Expert” under the SEC’s rules and regulations, possesses particular knowledge and experience in a variety of areas, including accounting and financial acumen, risk management, crisis management, innovation / research and development, regulatory and government affairs, and public company board experience (including specific experience in compensation, corporate relations, manufacturing, and social responsibility oversight) that strengthens the Board’s collective knowledge, capabilities and experience. 2019 Director Compensation and Benefits: Stephanie A. Burns Fees Earned or Paid in Cash $124,963; Stock Awards $155,037; Total $280,000.

Filing Date

Source Excerpt

2020-03-10

Stephanie A. Burns, Ph.D. Dr. Burns, age 65, has served as a Kellogg Director since February 2014. Dr. Burns served as Chief Executive Officer of Dow Corning Corporation from 2004 to 2011 and its Chairman from 2006 through 2011. She began her career with Dow Corning in 1983 and later became Dow Corning’s first director of women’s health. Dr. Burns was elected to the Dow Corning Board of Directors in 2001 and elected as President in 2003. Dr. Burns is a director of Corning Incorporated and HP Inc., and within the past five years, Dr. Burns has also served as a director of GlaxoSmithKline plc. As a result of these professional and other experiences, Dr. Burns has been determined to be an “Audit Committee Financial Expert” under the SEC’s rules and regulations, possesses particular knowledge and experience in a variety of areas, including accounting and financial acumen, risk management, crisis management, innovation / research and development, regulatory and government affairs, and public company board experience (including specific experience in compensation, corporate relations, manufacturing, and social responsibility oversight) that strengthens the Board’s collective knowledge, capabilities and experience. 2019 Director Compensation and Benefits: Stephanie A. Burns Fees Earned or Paid in Cash $124,963; Stock Awards $155,037; Total $280,000.

Data sourced from SEC filings. Last updated: 2025-07-01